Keyphrases
Vytorin
100%
Ezetimibe
100%
International Trial
100%
Acute Coronary Syndrome
66%
Simvastatin
44%
Low-density Lipoprotein Cholesterol (LDL-C)
22%
Statins
22%
Statin Intolerance
22%
Inclusion Criteria
11%
Veterans Affairs Healthcare System
11%
Health Systems
11%
Cardiovascular Outcomes
11%
Relative Risk Reduction
11%
Strict Criteria
11%
High-intensity Statin
11%
Large Potential
11%
Medicine and Dentistry
Ezetimibe/Simvastatin
100%
Ezetimibe
100%
Acute Coronary Syndrome
75%
Statin
62%
Simvastatin
37%
Health Care
25%
Low Density Lipoprotein Cholesterol
25%
Cardiovascular System
12%
Veterans Affairs
12%
Clinician
12%
Identified Patient
12%
Relative Risk Reduction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ezetimibe
100%
Ezetimibe Plus Simvastatin
100%
Acute Coronary Syndrome
75%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
37%
Simvastatin
37%
Statin (Protein)
25%
Low Density Lipoprotein Cholesterol
25%